Non-Commercial Pharmacies 2022 Overview

With approximately 28 million uninsured Americans in 2020, and millions more considered under-insured, Patient Assistance Programs (PAPs) and other free goods programs (including Medicare Part D patient assistance programs) have been introduced to help patients obtain the drugs they need.

Pharmaceutical companies who offer these programs and provide free or low-cost prescription drugs to patients who qualify hope that it helps patients comply with recommended drug therapies.[1] These programs are offered by the manufacturer and managed by hub service providers.

Pharmaceutical manufacturers work with hub service providers to increase access and adherence to these new drugs by developing and administering products and services for patients. Pharmaceutical manufacturer patient assistance support programs may include: Quick Start programs and Bridge programs.

To streamline the dispensing of these manufacturer provided products directly to patients in need, non-commercial pharmacies (NCPs) have been developed by hub service providers to serve this population. NCPs improve patient access to therapy by helping to reduce provider issues and simplifying the enrollment process.

AMI’s new report, Non-Commercial Pharmacies Overview, provides a brief background on the market and comprehensive profiles on the hub service providers offering non-commercial pharmacy services. These profiles include: company background, address/url/phone, top executives, financial/investor information, services and solutions and recent activities.

The report also includes information on each company’s non-commercial pharmacy including: address/phone, pharmacy executive, services, and NPI Identifier.

Table of Contents

Non-Commercial Pharmacies Background – pgs. 4-5 

Non-Commercial Pharmacies Profiles – pgs. 7-76

• AllCare Plus Pharmacy – pgs. 7-10
• AmerisourceBergen – Lash Group – pgs. 11-14
• AssistRx – pgs. 15-20
• Cardinal Health Specialty Solutions/Sonexus – pgs. 21-25
• CareMetx, LLC – pgs. 26-31
• ConnectiveRx – pgs. 32-35
• EVERSANA – pgs. 36-42
• Labcorp Drug Development – pgs. 43-46
• Medvantx – pgs. 47-49
• Optime Care, Inc. – pgs. 50-52
• PharmaCord LLC – pgs. 53-56
• RareMed Solutions – pgs. 57-60
• RIS Rx – pgs. 61-63
• RxCrossroads/CoverMyMeds – pgs. 64-68
• TrialCard Inc. – pgs. 69-73
• Truax Patient Services – pgs. 74-76

 

 

 

AMI’s new report is part of our Specialty Hub report services which will include the comprehensive Specialty Hub Provider 2022 report to be published in January

 

 

 

[1] United States Census Bureau; Health Insurance Coverage in the United States: 2020; September 14, 2021; Report Number P60-274; Katherine Keisler-Starkey and Lisa N. Bunch.